Itziar Lamiquiz-Moneo Selected Research

Itziar Lamiquiz-Moneo Research Topics

Disease

12	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023 - 07/2014
9	Hypercholesterolemia 01/2023 - 07/2014
6	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2020
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2019
5	Insulin Resistance 08/2022 - 01/2017
5	Obesity 01/2022 - 01/2017
4	Hypertriglyceridemia 12/2020 - 12/2014
3	Metabolic Diseases (Metabolic Disease) 03/2024 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2017
3	Body Weight (Weight, Body) 12/2020 - 01/2017
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 01/2018
3	Overweight 01/2020 - 01/2017
3	Xanthomatosis (Xanthoma) 01/2018 - 09/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 07/2014
2	Inflammation (Inflammations) 10/2022 - 01/2022
2	Weight Loss (Weight Reduction) 01/2020 - 01/2017
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Hyperlipoproteinemias 08/2021
1	Prediabetic State (Prediabetes) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 11/2019
1	Iron Overload 09/2018
1	Hyperferritinemia 09/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2018
1	Pancreatitis 01/2018
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2018
1	Arteriosclerosis 01/2017
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2014
1	Sitosterolemia 09/2014
1	Cholestasis 09/2014
1	Atherosclerosis 07/2014

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2023 - 01/2017
9	Apolipoproteins E (ApoE)IBA 09/2023 - 12/2014
9	CholesterolIBA 01/2023 - 09/2014
8	LDL CholesterolIBA 10/2022 - 01/2017
6	Apolipoproteins B (ApoB)IBA 08/2021 - 07/2014
5	Triglycerides (Triacylglycerol)IBA 09/2023 - 12/2014
4	NucleotidesIBA 01/2020 - 11/2017
4	SterolsIBA 01/2018 - 09/2014
3	Lipoprotein(a)IBA 01/2022 - 07/2014
3	Insulin (Novolin)FDA Link 01/2022 - 01/2020
3	oxidized low density lipoproteinIBA 08/2021 - 05/2018
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	CarbohydratesIBA 01/2020 - 01/2020
1	Blood Glucose (Blood Sugar)IBA 09/2023
1	Apolipoprotein E2IBA 01/2023
1	PlasminogenIBA 01/2022
1	27-hydroxycholesterolIBA 01/2022
1	24-hydroxycholesterolIBA 01/2022
1	OxysterolsIBA 01/2022
1	HyperglycerolemiaIBA 12/2020
1	Branched-Chain Amino AcidsIBA 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020
1	DextrinsIBA 01/2020
1	AdipokinesIBA 01/2020
1	isomaltulose (palatinose)IBA 01/2020
1	MaltoseIBA 01/2020
1	maltodextrinIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 11/2019
1	Ferritins (Ferritin)IBA 09/2018
1	IronIBA 09/2018
1	DesmosterolIBA 01/2018
1	gamma-sitosterol (beta-sitosterol)IBA 01/2018
1	campesterolIBA 01/2018
1	LanosterolIBA 01/2018
1	Monoclonal AntibodiesIBA 08/2017
1	AntibodiesIBA 08/2017
1	PCSK9 InhibitorsIBA 08/2017
1	3' Untranslated Regions (3' UTR)IBA 03/2017
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	Phytosterols (Plant Sterols)IBA 09/2014

Therapy/Procedure

3	Therapeutics 08/2021 - 01/2017
2	Glycemic Control 08/2022 - 01/2020
1	Mediterranean Diet 03/2024
1	Caloric Restriction 01/2020
1	Splenectomy 01/2018
1	High-Protein Diet 01/2017